Product NDC: | 0574-0106 |
Proprietary Name: | Bromocriptine mesylate |
Non Proprietary Name: | Bromocriptine mesylate |
Active Ingredient(s): | 2.5 mg/1 & nbsp; Bromocriptine mesylate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0574-0106 |
Labeler Name: | Paddock Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077646 |
Marketing Category: | ANDA |
Start Marketing Date: | 20081001 |
Package NDC: | 0574-0106-03 |
Package Description: | 24 BOTTLE in 1 CARTON (0574-0106-03) > 30 TABLET in 1 BOTTLE |
NDC Code | 0574-0106-03 |
Proprietary Name | Bromocriptine mesylate |
Package Description | 24 BOTTLE in 1 CARTON (0574-0106-03) > 30 TABLET in 1 BOTTLE |
Product NDC | 0574-0106 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Bromocriptine mesylate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20081001 |
Marketing Category Name | ANDA |
Labeler Name | Paddock Laboratories, Inc. |
Substance Name | BROMOCRIPTINE MESYLATE |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |